05:39:03 EDT Thu 25 Apr 2024
Enter Symbol
or Name
USA
CA



Imagin Medical Inc
Symbol IME
Shares Issued 139,060,278
Close 2019-02-15 C$ 0.10
Market Cap C$ 13,906,028
Recent Sedar Documents

Imagin Medical to release Q1 2019 results Feb. 27

2019-02-19 08:17 ET - News Release

Mr. Jim Hutchens reports

IMAGIN MEDICAL TO REPORT FIRST FISCAL QUARTER 2019 FINANCIAL RESULTS ON FEBRUARY 27, 2019 - CONFERENCE CALL TO FOLLOW

Imagin Medical Inc. will release its financial results for the first fiscal quarter ended Dec. 31, 2018, after market close on Wednesday, Feb. 27, 2019.

Imagin management will host a conference call at 5 p.m. ET to review the financial results and discuss business developments in the period.

Fiscal first quarter 2019 results conference call details

Date:  Feb. 27, 2019

Time:  5 p.m. ET

Live call:  888-428-7458 (Canada and the United States) or 862-298-0702 (international)

Replay:  919-882-2331

Replay ID:  43992

The call will also be broadcast live and archived on the company's website under events and presentations.

About Imagin Medical Inc.

Imagin Medical is a surgical imaging company focused on establishing a new standard of care in visualizing cancer during minimally invasive surgeries (MIS). The company believes its first product, the i/Blue imaging system, will dramatically improve surgeons' ability to visualize cancerous cells by producing higher-quality images more quickly compared with current methods. Based on advanced optics and light sensors, the i/Blue imaging system employs patented ultrasensitive imaging technology and offers easy-to-use viewing options for more accurate resection. The company's initial focus is bladder cancer.

We seek Safe Harbor.

© 2024 Canjex Publishing Ltd. All rights reserved.